Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s DiseaseMorteza Abyadeh, Mehdi Mirzaei, Ghasem Hosseini Salekdeh et al.|Aging and Disease|2021Cited by 62
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspectiveMorteza Abyadeh, Mehdi Mirzaei, Vivek Gupta et al.|Expert Review of Proteomics|2021Cited by 49